Clinical trial
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous…
NCT00221039 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00221039 |
|---|---|
| Title | Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A |
| Official title | UVADEX Sterile Solution in Conjunction With the UVAR XTS Photopheresis System as an Interventional Therapy for the Treatment Of CTCL (Mycosis Fungoides) in Patients With TMN Classification Stage 1A, 1B, 2A |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Boston Medical Center University of Pittsburgh Case Western Reserve University Vanderbilt University Medical Center University of Minnesota Rush University Medical Center Mallinckrodt Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cutaneous T Cell Lymphoma, Mycosis Fungoides |
| Intervention type | Drug |
| Interventions | Methoxsalen+ECP |
| Enrollment | 7 |
| Start date | Apr 2, 2004 |
| Primary completion | Apr 5, 2011 |
| Completion | Apr 5, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: